Merck & Co. Inc. Stock Underperforms Friday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Merck & Co. (MRK) shares fell 1.32% to $150.33 on Friday, underperforming competitors like Johnson & Johnson, Pfizer, and Eli Lilly during a broader market decline. The drop ended a three-day winning streak, leaving the stock 4.20% below its 52-week high. Trading volume was notably lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Merck & Co. Inc. (MRK) slid 1.32% to $150.33 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.38% to 7,718.60 and Dow Jones Industrial Average falling 0.51% to 53,414.25.
The stock's fall snapped a three-day winning streak.
Merck & Co. Inc. closed 4.20% below its 52-week high of $156.92, which the company achieved on August 25th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) fell 1.15% to $275.23, Pfizer Inc. (PFE) fell 1.25% to $28.45, and Eli Lilly & Co. (LLY) fell 0.88% to $1,149.36.
Trading volume (4.2 M) remained 5.9 million below its 50-day average volume of 10.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 4, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-04-26 1633ET